A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from ...

As prescription drug prices continue to spiral and federal efforts to control them stall, state lawmakers are focusing on ...

BofA raised the firm’s price target on CVS Health (CVS) to $75 from $63 and keeps a Buy rating on the shares. Aetna can add $3-$4 per share of ...

CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges ...

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high.

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...

CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

CVS Health Corporation (NYSE:CVS) is a retailer that operates in four segments: health care benefits, health services, ...

CVS Health executives cited tech-enabled home care provider Signify Health and primary care entity Oak Street for helping to generate profit growth in the fourth quarter of 2024.

CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...